Evaluation of low dose prazosin for PTSD-associated nightmares in children and adolescents
Introduction: Knowledge about fundamental sleep disorders and dysregulation that occurs in children with PTSD is limited. Prazosin is an alpha-1 receptor antagonist often used off label for the treatment of PTSD-associated nightmares in adults; however, evaluation of its use in pediatrics and adoles...
Saved in:
Main Authors: | Nancy Hudson, PharmD (Author), Steven Burghart, DPh, RPh, MBA, BCPP (Author), Jill Reynoldson, PharmD, BCPP, DPLA (Author), Dennis Grauer, MS, PhD (Author) |
---|---|
Format: | Book |
Published: |
American Association of Psychiatric Pharmacists,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of cannabis use on PTSD treatment outcomes in veterans
by: Meagan Petersen, PharmD, BCPP, et al.
Published: (2021) -
Comparison of clozapine doses and tolerability in patients with and without concurrent valproic acid
by: Ranel Troy Santos, PharmD, BCPP, et al.
Published: (2023) -
Impact of traditional versus nontraditional initiation dosing schedule of paliperidone palmitate on 30-day readmission and safety
by: Erika Kim, PharmD, BCPP, et al.
Published: (2023) -
Comparison of alpha-2 agonist versus alpha-1 antagonist for post-traumatic stress disorder-associated nightmares in pediatric patients
by: Seher Khalid, PharmD, et al.
Published: (2024) -
Microdose induction of buprenorphine-naloxone in a patient using high dose methadone: A case report
by: Menard Shannon PharmD, et al.
Published: (2021)